Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › MAZE

FARALLON CAPITAL MANAGEMENT, L.L.C. position in MAZE

MAZE THERAPEUTICS INC COM · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 1,107,814 shares of MAZE (MAZE THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$33.1M, representing 0.15% of its reported portfolio and ranking #43 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed MAZE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.11M sh
Reported value held$33.06M
Portfolio Weight0.15%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s MAZE position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in MAZE in Q1 2026 at 373,000 shares (US$11.1M). The position peaked in Q2 2026 at 1,107,814 shares, worth US$33.1M. Across 2 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,107,814 shares valued at US$33.1M — an increase of 734,814 shares quarter over quarter.. Notable position changes include a 197% increase in Q2 2026 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 373.00K $11.13M New
Q2 2026 1.11M $33.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MAZE and 13F data

MAZE (MAZE THERAPEUTICS INC COM) is a Health Care company. 74 other funds we track also report a position in MAZE — the largest reported positions include Frazier Life Sciences Management, L.P. (US$150.2M), TRV GP IV, LLC (US$133.5M), ARCH Venture Management, LLC (US$123.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MAZE

All MAZE fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held MAZE?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed MAZE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in MAZE?

As of Q2 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 1.11M shares of MAZE (MAZE THERAPEUTICS INC COM), valued at $33.06M, representing 0.15% of its reported portfolio and ranking #43.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling MAZE?

In the latest 13F filing (Q2 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. increased its position in MAZE. The position peaked in Q2 2026 at 1.11M shares.

Which other funds hold MAZE?

Other major institutional holders of MAZE include Frazier Life Sciences Management, L.P., TRV GP IV, LLC, ARCH Venture Management, LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.